A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancer

Okarnoto, T; Yano, T; Shimokawa, M; Takeo, S; Yamazaki, K; Sugio, K; Takenoyama, M; Nagashima, A; Tsukamoto, S; Hamatake, M; Yokoyama, H; Ueda, H; Motohiro, A; Tagawa, AT; Shoj, F; Kometanie, T; Saito, G; Fukuyamap, Y; Toyokawa, G; Osoegawa, A; Emie,

Okarnoto, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.

LUNG CANCER, 2018; 124 (): 255

Abstract

Objectives: Platinum-based combination chemotherapy is the standard postoperative adjuvant treatment for pathological stage II/III non-small cell lung......

Full Text Link